about
Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: Establishing baseline valuesEvidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimusA prospective, iterative, adaptive trial of carfilzomib-based desensitizationHigh Dimensional Renal Profiling: Towards a Better Understanding or Renal Transplant Immune SuppressionBelatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trialUse of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool
P50
Q47152860-0344C0C0-9416-4878-A23A-F8426D01070BQ90152690-E92341AB-78EA-4CF5-BCC0-149C384582CBQ90224727-1178D7FE-0E2A-45D3-981F-B06A03DC1B36Q90253674-8B439625-7EA5-4812-90DF-98BBE1DBB32FQ90599620-67F6CCB9-DFCF-4E57-9071-E0E9D368AD82Q91079262-EDDB6317-13D8-4AF0-A235-AF65A9809A60Q92140012-3955111F-504A-40C0-AE1F-0B3087094C17
P50
description
researcher
@en
name
Rita R Alloway
@en
type
label
Rita R Alloway
@en
prefLabel
Rita R Alloway
@en
P31
P496
0000-0003-4835-9197